The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 07, 2006

Filed:

Nov. 26, 2001
Applicants:

Markku Ahotupa, Turku, FI;

John Eriksson, Turku, FI;

Lauri Kangas, Lieto, FI;

Mikko Unkila, Littoinen, FI;

Janne Komi, Turku, FI;

Merja Perälä, Raisio, FI;

Helena Korte, Turku, FI;

Inventors:

Markku Ahotupa, Turku, FI;

John Eriksson, Turku, FI;

Lauri Kangas, Lieto, FI;

Mikko Unkila, Littoinen, FI;

Janne Komi, Turku, FI;

Merja Perälä, Raisio, FI;

Helena Korte, Turku, FI;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A01N 43/20 (2006.01); A61K 31/34 (2006.01); A23L 1/30 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention relates to a method of inhibiting myeloperoxidase activity in neutrophils in an individual by administering to the individual an effective amount of a lignan, where said lignan is enterolactone. The invention is further directed to a method inhibiting myeloperoxidase activity or oxidative burst of macrophages in an individual by administering to the individual an effective amount of a lignan where said lignan is enterolactone or hydroxymatairesinol or a mixture. Finally, the invention is directed to a method of inhibiting oxidative burst or myeloperoxidase activity in neutrophils in an individual by administering to the individual an effective amount of a lignan which is hydroxymatairesinol.


Find Patent Forward Citations

Loading…